Efficacy and Safety of

Adult Aged Aged, 80 and over Female Humans Lung Neoplasms / diagnostic imaging Male Middle Aged Neuroendocrine Tumors / diagnostic imaging Octreotide / adverse effects Organometallic Compounds / adverse effects Positron Emission Tomography Computed Tomography Radiopharmaceuticals / therapeutic use Retrospective Studies
bronchial carcinoid lung neuroendocrine tumor peptide receptor radionuclide therapy somatostatin receptor

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 2022
Historique:
received: 21 11 2020
revised: 21 04 2021
pubmed: 30 5 2021
medline: 3 3 2022
entrez: 29 5 2021
Statut: ppublish

Résumé

The purpose of this study was to assess the efficacy and safety of

Identifiants

DOI: 10.2967/jnumed.120.260760 PMID: 34049983 PMC: PMC8805789
pubmed: 34049983
pii: jnumed.120.260760
doi: 10.2967/jnumed.120.260760
pmc: PMC8805789
doi:

Substances chimiques

Ga(III)-DOTATOC 0
Organometallic Compounds 0
Radiopharmaceuticals 0
lutetium Lu 177 dotatate AE221IM3BB
Octreotide RWM8CCW8GP

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-225

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):302-11
pubmed: 21052661
Ann Oncol. 2015 Aug;26(8):1604-20
pubmed: 25646366
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2125-35
pubmed: 21892623
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):204-216
pubmed: 32572559
Clin Cancer Res. 2017 Aug 15;23(16):4617-4624
pubmed: 28428192
Neuroendocrinology. 2011;93(3):189-96
pubmed: 21335949
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Oncotarget. 2020 Jul 07;11(27):2636-2646
pubmed: 32676165
Eur J Nucl Med Mol Imaging. 2003 May;30(5):781-93
pubmed: 12707737
Ann Transl Med. 2018 Apr;6(8):146
pubmed: 29862235
Cancer Biother Radiopharm. 2009 Oct;24(5):527-33
pubmed: 19877882
Cancer Sci. 2018 Jan;109(1):174-181
pubmed: 29055056
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1040-6
pubmed: 26611427
Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1219-27
pubmed: 17260141
Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S219-23
pubmed: 10604135
Lancet Oncol. 2017 Dec;18(12):1652-1664
pubmed: 29074099
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988
pubmed: 29497803
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Neuroendocrinology. 2016;103(2):172-85
pubmed: 26731013
J Nucl Med. 2020 Dec;61(12):1764
pubmed: 33262268
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3278-3287
pubmed: 28605448
Clin Lung Cancer. 2019 May;20(3):e376-e392
pubmed: 30910575
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1869-75
pubmed: 20445977
Cancer Imaging. 2005 Jun 21;5:51-7
pubmed: 16154820
Thorac Surg Clin. 2014 Aug;24(3):333-49
pubmed: 25065935
J Natl Compr Canc Netw. 2018 Jun;16(6):693-702
pubmed: 29891520
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):441-52
pubmed: 26392198
Clin Nucl Med. 2017 Jun;42(6):428-435
pubmed: 28319500
J Oncol. 2012;2012:320198
pubmed: 22934111
Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):74-83
pubmed: 28533939

Auteurs

Lamiaa Zidan (L)

Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Amir Iravani (A)

Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Amir.iravani@wustl.edu.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Washington University School of Medicine, Mallinckrodt Institute of Radiology, St. Louis, Missouri.

Kira Oleinikov (K)

Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Simona Ben-Haim (S)

Department of Nuclear Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Institute of Nuclear Medicine, University College London and UCL Hospitals NHS Trust, London United Kingdom.

David J Gross (DJ)

Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Amichay Meirovitz (A)

Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and.

Ophra Maimon (O)

Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and.

Tim Akhurst (T)

Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Michael Michael (M)

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Division of Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Rodney J Hicks (RJ)

Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Simona Grozinsky-Glasberg (S)

Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Grace Kong (G)

Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Efficacy and Safety of
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Efficacy and Safety of
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Efficacy and Safety of
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Efficacy and Safety of
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Efficacy and Safety of
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Efficacy and Safety of
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Efficacy and Safety of
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Peptides cycliques › Octréotide › Efficacy and Safety of
questionsmedicales.fr › Composés chimiques organiques › Composés organométalliques › Efficacy and Safety of
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Efficacy and Safety of
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › Efficacy and Safety of
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Efficacy and Safety of